Abstract
The relationship between electrocardiographic-left ventricular hypertrophy (ECG-LVH) and stroke has been well established in the Western population with limited information in the Chinese population. This study evaluated the association between ECG-LVH and stroke outcome. A total of 19,815 (95.7%) subjects from the China Stroke Primary Prevention Trial (CSPPT) with baseline ECG were included. ECG-LVH by sex-unspecific Sokolow-Lyon criteria was detected in 1599 participants (8.1%) at baseline. After a mean follow-up of 4.5 years, 605 (3.1%) subjects were detected with new-onset stroke over the total population, baseline ECG-LVH was present in 72 (4.5%) of them during follow-up. After adjusting for various cofounders, ECG-LVH remained as an independent risk factor for stroke events in the total population (HR = 1.43; 95% CI, 1.10–1.84; P = 0.007) and male population (HR = 1.47; 95% CI, 1.07–2.03; P = 0.019). Subgroup analysis showed that baseline ECG-LVH was a risk factor for stroke in individuals younger than 65 years of age(HR = 1.80, 95% CI, 1.31–2.47 vs. HR = 1.02, 95% CI, 0.66–1.59, P value for interaction = 0.047). In summary, LVH diagnosed by ECG is associated with an excess risk for stroke in Chinese hypertensive population, especially in the age group of younger than 65 years.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380:2095–128.
Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, Chaturvedi S, et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke. 2011;42:517–84.
Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics--2013 update: a report from the American heart association. Circulation. 2013;127:e6–245.
Ofoma U, He F, Shaffer ML, Naccarelli GV, Liao D. Premature cardiac contractions and risk of incident ischemic stroke. J Am Heart Assoc. 2012;1:e002519.
Bikkina M, Levy D, Evans JC, Larson MG, Benjamin EJ, Wolf PA, et al. Left ventricular mass and risk of stroke in an elderly cohort. The framingham heart study. JAMA. 1994;272:33–6.
Verdecchia P, Porcellati C, Reboldi G, Gattobigio R, Borgioni C, Pearson TA, et al. Left ventricular hypertrophy as an independent predictor of acute cerebrovascular events in essential hypertension. Circulation. 2001;104:2039–44.
Ishikawa J, Ishikawa S, Kabutoya T, Gotoh T, Kayaba K, Schwartz JE, et al. Jichi Medical School Cohort Study Investigators G. Cornell product left ventricular hypertrophy in electrocardiogram and the risk of stroke in a general population. Hypertension. 2009;53:28–34.
O’Neal WT, Almahmoud MF, Qureshi WT, Soliman EZ. Electrocardiographic and echocardiographic left ventricular hypertrophy in the prediction of stroke in the elderly. J Stroke Cerebrovasc Dis. 2015;24:1991–7.
Wolf PA, D’Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham study. Stroke. 1991;22:312–8.
Wu X, Zhu B, Fu L, Wang H, Zhou B, Zou S, et al. Prevalence, incidence, and mortality of stroke in the Chinese island populations: a systematic review. PLoS ONE. 2013;8:e78629.
Huo Y, Li J, Qin X, Huang Y, Wang X, Gottesman RF, et al. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in china: the CSPPT randomized clinical trial. JAMA. 2015;313:1325–35.
Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J. 1949;37:161–86.
Cuspidi C, Sala C, Negri F, Mancia G, Morganti A, Italian Society of Hypertension. Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies. J Hum Hypertens. 2012;26:343–9.
Salles GF, Cardoso CR, Fiszman R, Muxfeldt ES. Prognostic impact of baseline and serial changes in electrocardiographic left ventricular hypertrophy in resistant hypertension. Am Heart J. 2010;159:833–40.
Jissho S, Shimada K, Taguchi H, Yoshida K, Fukuda S, Tanaka H, et al. Impact of electrocardiographic left ventricular hypertrophy on the occurrence of cardiovascular events in elderly hypertensive patients—the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (jatos). Circ J. 2010;74:938–45.
Antikainen RL, Grodzicki T, Palmer AJ, Beevers DG, Webster J, Bulpitt CJ, et al. Department of Health and Social Security Hypertension Care Computer Project. Left ventricular hypertrophy determined by Sokolow-Lyon criteria: a different predictor in women than in men?. J Hum Hypertens. 2006;20:451–9.
Kumpusalo E, Lappi J, Miettinen H, Takala J. Prevalence of left ventricular hypertrophy in finnish primary health care hypertensive patients. J Hum Hypertens. 2001;15:255–8.
Pewsner D, Juni P, Egger M, Battaglia M, Sundstrom J, Bachmann LM. Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review. BMJ. 2007;335:711.
Porthan K, Niiranen TJ, Varis J, Kantola I, Karanko H, Kahonen M, et al. ECG left ventricular hypertrophy is a stronger risk factor for incident cardiovascular events in women than in men in the general population. J Hypertens. 2015;33:1284–90.
Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Dahlof B. Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the losartan intervention for endpoint reduction (life) in hypertension study. The life study investigators. Hypertension. 2000;36:766–73.
Verdecchia P, Dovellini EV, Gorini M, Gozzelino G, Lucci D, Milletich A, et al. Comparison of electrocardiographic criteria for diagnosis of left ventricular hypertrophy in hypertension: the MAVI study. Ital Heart J. 2000;1:207–15.
Blake J, Devereux RB, Herrold EM, Jason M, Fisher J, Borer JS, et al. Relation of concentric left ventricular hypertrophy and extracardiac target organ damage to supranormal left ventricular performance in established essential hypertension. Am J Cardiol. 1988;62:246–52.
Shigematsu Y, Hamada M, Mukai M, Matsuoka H, Sumimoto T, Hiwada K. Clinical evidence for an association between left ventricular geometric adaptation and extracardiac target organ damage in essential hypertension. J Hypertens. 1995;13:155–60.
Verdecchia P, Reboldi G, Schillaci G, Borgioni C, Ciucci A, Telera MP, et al. Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension. Circulation. 1999;100:1802–7.
Messerli FH, Ventura HO, Elizardi DJ, Dunn FG, Frohlich ED. Hypertension and sudden death. Increased ventricular ectopic activity in left ventricular hypertrophy. Am J Med. 1984;77:18–22.
McLenachan JM, Henderson E, Morris KI, Dargie HJ. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N Engl J Med. 1987;317:787–92.
Acknowledgements
The authors appreciate the participants who volunteered to participate in the study, and the data collection staff of the CSPPT team.
Funding
The study was supported by National Science and Technology Major Projects Specialized for “Precision Medicine Research” during the 13th Five-Year Plan Period (No. 2016YFC0903100); the State Key Program of National Natural Science Foundation of China (No. 81530015 to Y.G.L); Projects of National Natural Science Foundation of China (Nos. 81473052 and 81402735 to Y.G.L); the Science, Technology and Innovation Committee of Shenzhen (No. JCYL20130401162636527); the Department of Development and Reform, Shenzhen Municipal Government (No. SFG 20201744); the Special Project on the Integration of Industry, Education and Research of Guangdong Province (No. 2011A091000031); and the Science and Technology Planning Project of Guangdong Province, China (No. 2014B090904040).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhao, Y., Huang, X., Zhang, PP. et al. Electrocardiographic-left ventricular hypertrophy and incident stroke among Chinese hypertensive adults. J Hum Hypertens 34, 286–292 (2020). https://doi.org/10.1038/s41371-018-0155-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41371-018-0155-x